Cargando…

Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor

OBJECTIVE: We investigated the differential roles of apolipoprotein E (apoE) isoforms in modulating diabetic dyslipidemia—a potential cause of the increased cardiovascular disease risk of patients with diabetes. RESEARCH DESIGN AND METHODS: Diabetes was induced using streptozotocin (STZ) in human ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Lance A., Arbones-Mainar, Jose M., Fox, Raymond G., Pendse, Avani A., Altenburg, Michael K., Kim, Hyung-Suk, Maeda, Nobuyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161311/ https://www.ncbi.nlm.nih.gov/pubmed/21810592 http://dx.doi.org/10.2337/db11-0466

Ejemplares similares

Pparg-P465L Mutation Worsens Hyperglycemia in Ins2-Akita Female Mice via Adipose-Specific Insulin Resistance and Storage Dysfunction
por: Pendse, Avani A., et al.
Publicado: (2010)

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance
por: Mulvihill, Erin E., et al.
Publicado: (2011)

Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice
por: Cao, Qiang, et al.
Publicado: (2016)

Quantitative Trait Loci Affecting Atherosclerosis at the Aortic Root Identified in an Intercross between DBA2J and 129S6 Apolipoprotein E-Null Mice
por: Kayashima, Yukako, et al.
Publicado: (2014)

Oxidized LDL, insulin sensitivity and beta-cell function in newborns
por: Fang, Fang, et al.
Publicado: (2021)

The Apolipoprotein E Polymorphism rs7412 Associates with Body Fatness Independently of Plasma Lipids in Middle Aged Men
por: Tejedor, M. Teresa, et al.
Publicado: (2014)

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
por: Mulvihill, Erin E., et al.
Publicado: (2009)

Chronic environmental circadian disruption increases atherosclerosis and dyslipidemia in female, but not male, ApolipoproteinE-deficient mice
por: Chalfant, Jeffrey M., et al.
Publicado: (2023)

Identification of Aortic Arch-Specific Quantitative Trait Loci for Atherosclerosis by an Intercross of DBA/2J and 129S6 Apolipoprotein E-Deficient Mice
por: Kayashima, Yukako, et al.
Publicado: (2015)

Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance
por: Boon, James, et al.
Publicado: (2013)

Impaired LDL Receptor-Related Protein 1 Translocation Correlates with Improved Dyslipidemia and Atherosclerosis in apoE-Deficient Mice
por: Gordts, Philip L.S.M., et al.
Publicado: (2012)

ALERT-LDL: adherence to guidelines in the treatment of patients with dyslipidemia
por: Bosso, Giorgio, et al.
Publicado: (2021)

Apolipoprotein E2 Accentuates Postprandial Inflammation and Diet-Induced Obesity to Promote Hyperinsulinemia in Mice
por: Kuhel, David G., et al.
Publicado: (2013)

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
por: Farnier, Michel, et al.
Publicado: (2014)

Cardiorespiratory fitness decreases the odds for subclinical carotid plaques in apolipoprotein e4 homozygotes
por: Perez-Lasierra, Jose Luis, et al.
Publicado: (2022)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

Association with inflammatory cells and apolipoproteins to the progression of atherosclerosis
por: Eo, Hyun-Seon, et al.
Publicado: (2011)

Bariatric surgery and LDL cholesterol (BASALTO) trial study protocol: randomised controlled study evaluating the effect of gastric bypass versus sleeve gastrectomy on high LDL cholesterol
por: Benaiges, David, et al.
Publicado: (2020)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Exaggeration
por: Chandler, J. B.
Publicado: (1880)

Atherosclerosis: visualising oxidised LDL in zebrafish
Publicado: (2012)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Recycling the LDL receptor to combat atherosclerosis
por: Vos, Dyonne, et al.
Publicado: (2018)

Atherosclerosis in Different Vascular Locations Unbiasedly Approached with Mouse Genetics
por: Kayashima, Yukako, et al.
Publicado: (2020)

apoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes
por: Ramanjaneya, Manjunath, et al.
Publicado: (2021)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Can Physical Activity Reduce the Risk of Cognitive Decline in Apolipoprotein e4 Carriers? A Systematic Review
por: Perez-Lasierra, Jose Luis, et al.
Publicado: (2021)

Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice
por: Maezawa, Izumi, et al.
Publicado: (2006)

An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E(-/-) mice
por: Peng, Nan, et al.
Publicado: (2014)

Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice
por: Wang, Rong, et al.
Publicado: (2016)

Zebrafish Models for Dyslipidemia and Atherosclerosis Research
por: Schlegel, Amnon
Publicado: (2016)

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

Obesity, Dyslipidemia, Diabetes, and Vitamin D Levels
por: Moya, Elena A Amoroso, et al.
Publicado: (2021)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013)

Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
por: Faghihnia, Nastaran, et al.
Publicado: (2012)

Alcohol and Exaggeration
Publicado: (1908)

Cannot write session to /tmp/vufind_sessions/sess_p998t507e8ifq8lllutg3nbmm9